Kimura disease

WikiDoc Resources for Kimura disease
Articles
Most recent articles on Kimura disease Most cited articles on Kimura disease Review articles on Kimura disease Articles on Kimura disease in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Kimura disease Images of Kimura disease Photos of Kimura disease Podcasts & MP3s on Kimura disease Videos on Kimura disease
Evidence Based Medicine
Cochrane Collaboration on Kimura disease Bandolier on Kimura disease TRIP on Kimura disease
Clinical Trials
Ongoing Trials on Kimura disease at Clinical Trials.gov Trial results on Kimura disease Clinical Trials on Kimura disease at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Kimura disease NICE Guidance on Kimura disease NHS PRODIGY Guidance FDA on Kimura disease CDC on Kimura disease
Books
Books on Kimura disease
News
Kimura disease in the news Be alerted to news on Kimura disease News trends on Kimura disease
Commentary
Blogs on Kimura disease
Definitions
Definitions of Kimura disease
Patient Resources / Community
Patient resources on Kimura disease Discussion groups on Kimura disease Patient Handouts on Kimura disease Directions to Hospitals Treating Kimura disease Risk calculators and risk factors for Kimura disease
Healthcare Provider Resources
Symptoms of Kimura disease Causes & Risk Factors for Kimura disease Diagnostic studies for Kimura disease Treatment of Kimura disease
Continuing Medical Education (CME)
CME Programs on Kimura disease
International
Kimura disease en Espanol Kimura disease en Francais
Business
Kimura disease in the Marketplace Patents on Kimura disease
Experimental / Informatics
List of terms related to Kimura disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Lakshmi Gopalakrishnan, M.B.B.S. [2]

Overview

Kimura disease is a benign, rare, chronic inflammatory disorder. Its primary symptoms include: subdermal lesions present in the head or neck and is associated with painless unilateral cervical lymph nodes inflammation.

Historical Perspective

The first known report of Kimura disease was from China in 1937, when Kimm and Szeto identified seven cases of the condition.

It first received its name in 1948 when Kimura and others noted a change in the surrounding blood vessels and referred to it as unusual granulation combined with hyperplastic changes in lymphoid tissue.

Pathophysiology

The pathophysiology of Kimura Disease remains unknown, although an allergic reaction, trauma, and/or autoimmune process have all been implicated as possible etiology.

The disease is manifested by an abnormal proliferation of lymphoid follicles and vascular endothelium. Peripheral eosinophilia and the presence of eosinophils in the inflammatory infiltrate suggest that Kimura Disease may be an hypersensitivity reaction. Some evidence has indicated that TH2 lymphocytes may also play a role, but further investigation is needed.

Kimura Disease is generally limited to the skin, lymph nodes, and salivary glands, but patients presenting with nephrotic syndrome have also been reported. The basis of this possible association is unclear.

Epidemiology & Demographics

Kimura Disease is predominantly seen in males of Asian descent. The disease has rarely been reported in the United States. On an international level, the prevalence of the disease is not known.

Cause

The cause of Kimura disease remains unknown. Allergic reaction or an alteration of immune regulation or persistent antigenic stimulation following arthropod bites and parasitic or candidal infection have been postulated. However, none of these theories have been substantiated till date.

Treatment

Medical Therapy

• Observation if the lesions are neither symptomatic nor disfiguring.

• Intralesional or oral steroids may be indicated to reduce the size of the nodules but seldom result in cure.

• Cyclosporine has been reported to induce remission in patients with Kimura Disease. However, recurrence of the lesion have been observed on discontinuation of the therapy.

• Cetirizine is an effective agent in treating the symptoms of Kimura's disease. Cetirizine's properties of being effective both in the treatment of pruritus and as an anti-inflammatory agent make it suitable for the treatment of the pruritus associated with these lesions.

Supportive data

In a 2005 study, the American College of Rheumatology conducted treatments initially using prednisone, followed by steroid dosages and azathioprine, omeprazole, calcium and vitamin D supplements over the course of two years. The skin condition of the patient began to improve and the skin lesions lessened. However, there were symptoms of cushingoid and hirsutism observed before the patient was removed from the courses of steroids and placed on 10 mg/day of cetirizine to prevent skin lesions; an agent suitable for the treatment of pruritus associated with such lesions. Asymptomatically, the patient's skin lesions disappeared after treatment with cetirizine, blood eosinophil counts became normal, corticosteroid effects were resolved, and a remission began within a period of two months. It is also thought that the inhibition of eosinophils may be the key to treatment of Kimura's disease due to the role of eosinophils, rather than other cells with regards to the lesions of the skin.

Radiotherapy

Radiotherapy has been used to treat recurrent or persistent lesions. However, considering the benign nature of this disease, radiation should be considered only in cases of recurrent, disfiguring lesions.

Surgery

Surgery has been considered the mainstay of therapy. However, recurrence after surgery is common.

Physical examination

• 

  Kimura Disease.
  With permission from the Dermatology Atlas